ABL BIOTEC A/S: Financial statements 2012
CVR: 50811018
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -50,503 and a net result of DKK 3,685,841. Equity in the 2012 report amounted to DKK 21,513,448. The solvency ratio was 99.8%.
- Gross Profit
- DKK -50,503
- Profit/Loss
- DKK 3,685,841
- Equity
- DKK 21,513,448
- Total Assets
- DKK 21,550,630
Official annual report
Keep an eye on ABL BIOTEC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 31, 2012, ALBERT PEDERSEN. STATSAUTORISEREDEREVISORER I/S has stepped down as auditor of ABL BIOTEC A/S.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named KONTORBUTIKKEN ApS and PAPIR EN GROS VIGGO TRANHOLM MADSEN ApS. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.
